Benitec Biopharma

BNTCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$303.188 M

$8.69 -6.36%

Close of 6 Nov 2026

As of 6 Nov 2026, Benitec Biopharma (BNTC) has a market capitalization of $303.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$37.9M

Loss-making

Shares outstanding

34,882,726

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#215Aspen NeuroscienceASPE$335.0M
#216Opus GeneticsIRD$334.0M
#217Benitec BiopharmaBNTC$303.2M
#218Galectin TherapeuticsGALT$301.2M
#219Emergent BioSolutionsEBS$300.0M

What if Benitec Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$809,327.31

Per share 93,133× higher

Bitcoin $1.53T

$43,791.29

Per share 5,039× higher

Apple $5.02T

$143,762.72

Per share 16,543× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Benitec Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.